pharmaceuticals

White House Releases Long-Overdue Federal Rulemaking Agenda

The Office of Information and Regulatory Affairs (OIRA) has finally released the Trump administration's overdue Unified Agenda of Regulatory and…

July 13, 2026

TrumpRx Now Features Generic Meds, Still Doesn’t Lower Drug Prices

President Donald Trump’s direct-to-consumer website for pharmaceutical discounts is expanding significantly. On May 18, the White House announced that TrumpRx…

May 19, 2026

FDA Eyeing “Drug Disposal” Products, for Destroying Rx Opioids at Home

The Food and Drug Administration is asking the public to weigh in on the merits of commercial drug-disposal products, for…

March 11, 2026

FDA Drops Drug-Approval Standard From Two Controlled Trials to One

The Food and Drug Administration will no longer expect pharmaceutical manufacturers to submit two pivotal trials in applications for new…

February 23, 2026

TrumpRx Launches, Offering Drug Discounts as Long as You Pay Cash

On February 5 President Donald Trump launched TrumpRx.gov, a direct-to-consumer website listing pharmaceutical medications at reduced prices that the administration…

February 6, 2026

Landmark Deals Drop New Injectable PrEP From $28,000 to $40—for Some

Lenacapavir, the new long-acting HIV prevention medication that hit the United States market with a price tag of over $28,000…

September 24, 2025

Feds Crack Down on TV Drug Ads, in Major Shakeup to Pharma Industry

The era of direct-to-consumer (DTC) pharmaceutical commercials may be coming to a close. On September 9, President Donald Trump signed…

September 11, 2025

FDA Requires All Rx Opioid Labeling Warn About Risks of Long-Term Use

The Food and Drug Administration is overhauling the safety labeling requirements for opioid analgesics, citing new evidence that problematic use…

August 5, 2025

The Golden Age of Doctor-Shopping

In 2012, right before prescription drug-monitoring programs (PDMP) shut everything down, I was seeing 11 doctors every month—the same 11…

April 29, 2025

Walgreens Settles DOJ Prescription Opioid Lawsuit, Likely at $350 Million

Walgreens, the nation’s second-largest pharmacy chain, will pay $300 million plus 4 percent interest to settle Department of Justice allegations…

April 22, 2025